Ball Geoff D C, Merdad Roah, Birken Catherine S, Cohen Tamara R, Goodman Brenndon, Hadjiyannakis Stasia, Hamilton Jill, Henderson Mélanie, Lammey John, Morrison Katherine M, Moore Sarah A, Mushquash Aislin R, Patton Ian, Pearce Nicole, Ramjist Joshua K, Lebel Tracy Rhyason, Timmons Brian W, Buchholz Annick, Cantwell Jennifer, Cooper Jennifer, Erdstein Julius, Fitzpatrick-Lewis Donna, Hatanaka Dawn, Lindsay Patrice, Sajwani Tasneem, Sebastianski Meghan, Sherifali Diana, Pierre Julie St, Ali Muhammad Usman, Wijesundera Jessica, Alberga Angela S, Ausman Christine, Baluyot Trisha C, Burke Emily, Dadgostar Kara, Delacruz Bronwyn, Dettmer Elizabeth, Dymarski Maegan, Esmaeilinezhad Zahra, Hale Ilona, Harnois-Leblanc Soren, Ho Josephine, Gehring Nicole D, Kucera Marsha, Langer Jacob C, McPherson Amy C, Naji Leen, Oei Krista, O'Malley Grace, Rigsby Angelica M, Wahi Gita, Zenlea Ian S, Johnston Bradley C
Department of Pediatrics, Faculty of Medicine & Dentistry, College of Health Sciences (Ball, Wijesundera), University of Alberta, Edmonton, Alta.; Department of Community Medicine, Faculty of Medicine (Merdad), King Abdulaziz University, Jeddah, Saudi Arabia; The Hospital for Sick Children and Department of Pediatrics (Birken), University of Toronto, Toronto, Ont.; Faculty of Land and Food Systems, Food, Nutrition and Health (Cohen), University of British Columbia, Vancouver, BC; Youth representative (Goodman), Toronto, Ont.; Department of Pediatrics, Faculty of Medicine (Hadjiyannakis), Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ont.; Division of Endocrinology, Hospital for Sick Children, Department of Paediatrics, University of Toronto (Hamilton), Toronto, Ont.; Department of Pediatrics, Université de Montréal and Centre de Recherche CHU Sainte-Justine and School of Public Health, Department of Social and Preventive Medicine, Université de Montréal (Henderson), Montréal, Que.; Family representative (Lammey), Ottawa, Ont.; Department of Pediatrics, Centre for Metabolism, Obesity and Diabetes Research (Morrison), McMaster University, Hamilton, Ont.; Dalhousie University (Moore), Halifax, NS; Department of Psychology (Mushquash), Lakehead University, Thunder Bay, Ont.; Obesity Canada (Patton, Pearce), Edmonton, Alta.; Division of General & Thoracic Surgery, The Hospital for Sick Children and Department of Surgery, Temerty School of Medicine, University of Toronto (Ramjist), Toronto, Ont.; Family representative (Lebel), Edmonton, Alta.; McMaster University (Timmons), Hamilton, Ont.; Children's Hospital for Eastern Ontario (Buchholz), Ottawa, Ont.; Family representative (Cantwell, Cooper), Toronto, Ont.; McGill University (Erdstein), Montréal, Que.; School of Nursing, Faculty of Health Sciences (Fitzpatrick-Lewis, Sherifali), McMaster University, Hamilton, Ont.; University of Alberta (Hatanaka), Edmonton, Alta.; Heart and Stroke Foundation (Lindsay), Toronto, Ont.; Edmonton Weight Management Centre & Family Clinic (Sajwani), Edmonton, Alta.; Cochrane Collaboration (Sebastianski), Edmonton, Alta.; Department of Pediatrics (St. Pierre), McGill University, Montréal, Que.; Department of Health Research, Evidence and Impact, Faculty of Health Sciences (Ali), McMaster University, Hamilton, Ont.; Department of Health, Kinesiology, and Applied Physiology (Alberga, Baluyot), Concordia University, Montréal, Que.; School of Health and Human Performance, Faculty of Health (Ausman), Dalhousie University, Halifax, NS; University of Calgary (Delacruz, Kucera), Calgary, Alta.; School of Health and Human Performance (Burke), Dalhousie University, Halifax, NS; Lakehead University (Dadgostar), Thunder Bay, Ont.; The Hospital for Sick Children (Dettmer, Langer, Oei), Toronto, Ont.; Department of Psychology (Dymarski), Carleton University, Ottawa, Ont.; Department of Nutrition, College of Agriculture and Life Sciences (Esmaeilinezhad, Johnston, Rigsby), Texas A&M University, College Station, Tex.; University of British Columbia (Hale), Kimberley, BC; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute (Harnois-Leblanc), Boston, Mass.; Centre de recherche Azrieli, CHU Sainte-Justine (Harnois-Leblanc), Montréal, Que.; Division of Endocrinology, Department of Pediatrics, Cumming School of Medicine (Ho), University of Calgary, Calgary, Alta.; School of Public Health, College of Health Sciences (Gehring), University of Alberta, Edmonton, Alta.; Holland Bloorview Rehabilitation Hospital (McPherson), Toronto, Ont.; Department of Family Medicine (Naji), McMaster University, Hamilton, Ont.; School of Physiotherapy (O'Malley), Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, Ireland; Department of Pediatrics (Wahi), McMaster University, McMaster Children's Hospital, Hamilton, Ont.; Institute for Better Health (Zenlea), Trillium Health Partners, Mississauga, Ont.
CMAJ. 2025 Apr 13;197(14):E372-E389. doi: 10.1503/cmaj.241456.
Obesity is a complex, chronic, stigmatized disease whereby abnormal or excess body fat may impair health or increase the risk of medical complications, and can reduce quality of life and shorten lifespan in children and families. We developed this guideline to provide evidence-based recommendations on options for managing pediatric obesity that support shared decision-making among children living with obesity, their families, and their health care providers.
We followed the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. We used the Guidelines International Network principles to manage competing interests. Caregivers, health care providers, and people living with obesity participated throughout the guideline development process, which optimized relevance. We surveyed end users (caregivers, health care providers) to prioritize health outcomes, completed 3 scoping reviews (2 on minimal important difference estimates; 1 on clinical assessment), performed 1 systematic review to characterize families' values and preferences, and conducted 3 systematic reviews and meta-analyses to examine the benefits and harms of behavioural and psychological, pharmacologic, and surgical interventions for managing obesity in children. Guideline panellists developed recommendations focused on an individualized approach to care by using the GRADE evidence-to-decision framework, incorporating values and preferences of children living with obesity and their caregivers.
Our guideline includes 10 recommendations and 9 good practice statements for managing obesity in children. Managing pediatric obesity should be guided by a comprehensive child and family assessment based on our good practice statements. Behavioural and psychological interventions, particularly multicomponent interventions (strong recommendation, very low to moderate certainty), should form the foundation of care, with tailored therapy and support using shared decision-making based on the potential benefits, harms, certainty of evidence, and values and preferences of children and families. Pharmacologic and surgical interventions should be considered (conditional recommendation, low to moderate certainty) as therapeutic options based on availability, feasibility, and acceptability, and guided by shared decision-making between health care providers and families.
This guideline will support children, families, and health care providers to have informed discussions about the balance of benefits and harms for available obesity management interventions to support value- and preference-sensitive decision-making.
肥胖是一种复杂的慢性疾病,会遭人诟病,体内异常或过多的脂肪可能损害健康或增加医疗并发症风险,还会降低儿童及其家庭的生活质量并缩短寿命。我们制定本指南,旨在为儿童肥胖管理方案提供循证建议,以支持肥胖儿童、其家庭及医疗服务提供者之间的共同决策。
我们遵循了推荐分级的评估、制定和评价(GRADE)方法。我们运用国际指南网络原则来管理利益冲突。照顾者、医疗服务提供者和肥胖患者全程参与了指南制定过程,从而优化了指南的相关性。我们对终端用户(照顾者、医疗服务提供者)进行了调查,以确定健康结果的优先级,完成了3项范围综述(2项关于最小重要差异估计;1项关于临床评估),进行了1项系统综述以描述家庭的价值观和偏好,并开展了3项系统综述和荟萃分析,以研究行为和心理、药物及手术干预措施在儿童肥胖管理中的益处和危害。指南小组成员运用GRADE证据到决策框架,结合肥胖儿童及其照顾者的价值观和偏好,制定了侧重于个性化护理方法的建议。
我们的指南包括10条关于儿童肥胖管理的建议和9条良好实践声明。儿童肥胖管理应以基于我们良好实践声明的全面儿童及家庭评估为指导。行为和心理干预措施,特别是多成分干预措施(强烈推荐,极低至中等确定性),应构成护理的基础,并根据潜在益处、危害、证据确定性以及儿童和家庭的价值观和偏好,通过共同决策提供量身定制的治疗和支持。基于可及性、可行性和可接受性,并在医疗服务提供者和家庭之间共同决策的指导下,应考虑将药物和手术干预措施(有条件推荐,低至中等确定性)作为治疗选择。
本指南将支持儿童、家庭和医疗服务提供者就是否采用现有肥胖管理干预措施的利弊进行充分讨论,以支持基于价值观和偏好的明智决策。